Consequences of Direct-to-Consumer Advertising: Links to Higher Prices and Less Competition

Consequences of Direct-to-Consumer Advertising Links to Higher Prices and Less Competition

This articlefocuses on a new study that suggests drug price increases areengineered to cover the costs of Direct-to-Consumer Advertising (DTCA).Drug price trend data from AARP, AHRQ, and prescription drug consumerprice index (CPI) are presented.

Topic headings include:

• AARP Rx Watchdog Report Data
• Flaws in the AARP Report
• Engineered Drug Price Increase
• DTC Ad Spend Chart
• Industry Says No Direct Link to DTC
• Plavix and Medicaid
• Smoking Gun Charts
• Pharmacos Spend More on DTCA When There is No Competition
• Plausible or Dubious?

Read this article now. It’s FREE…

Download PDF file

PMN810-01
Issue: Vol. 8, No. 10: Nov/Dec 2009
Word Count: 2802

Find other articles in related Topic Areas:

• Direct-to-Consumer (DTC) Advertising & Marketing
• Brand Marketing